RAND Europe, Westbrook Centre Milton Road, Cambridge, CB4 1YG, UK.
Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Orphanet J Rare Dis. 2022 Feb 16;17(1):58. doi: 10.1186/s13023-022-02191-2.
Central diabetes insipidus (CDI) is a rare condition, with significant impact on patient health and well-being. It is a chronic condition which usually requires meticulous long-term care. It can affect both children and adults. There is limited literature considering the needs and challenges inherent in providing high quality care to patients with CDI, across the care pathway. This paper seeks to address this gap by providing a unique and well-rounded understanding of clinical and healthcare systems-related challenges. It draws on insights from the literature, from direct clinical experience contributed by five clinicians as co-authors (providing insights from France, Ireland, Italy, Spain and the United Kingdom), and from patient perspectives provided through interviews with patient representatives from three patient organisations. We identify clinical challenges related to the diagnosis of CDI, including differentiating between other similar conditions and determining the underlying aetiology. Treatment is challenging, given the need to tailor medication to each patient's needs and ongoing management is required to ensure that patients continue to respond adequately to treatment. Ongoing support is required when patients switch between formulations. We also identify healthcare systems challenges related to limited awareness of CDI amongst primary care physicians and general paediatricians, and the need for highly skilled specialist care and appropriate workforce capacity. There is also a significant need for raising awareness and for the education of both healthcare professionals and patients about different aspects of CDI, with the aim of supporting improved care and effective patient engagement with healthcare professionals. We reflect on this information and highlight improvement opportunities. These relate to developing guidance to support patients, carers, primary care physicians and general paediatricians to identify clinical features earlier, and to consider CDI as a possible diagnosis when a patient presents with suggestive symptoms.
中枢性尿崩症(CDI)是一种罕见的疾病,对患者的健康和福祉有重大影响。它是一种慢性病,通常需要精心的长期护理。它可以影响儿童和成人。关于在整个护理路径中为 CDI 患者提供高质量护理的需求和挑战,相关文献有限。本文旨在通过提供对临床和医疗保健系统相关挑战的独特而全面的理解来填补这一空白。它借鉴了文献、五位临床医生(来自法国、爱尔兰、意大利、西班牙和英国)作为合著者提供的直接临床经验以及通过与来自三个患者组织的患者代表进行访谈获得的患者观点。我们确定了与 CDI 诊断相关的临床挑战,包括区分其他类似病症和确定潜在病因。治疗具有挑战性,因为需要根据每个患者的需求调整药物,并且需要进行持续管理以确保患者继续对治疗有足够的反应。当患者在剂型之间转换时,需要持续支持。我们还确定了与初级保健医生和普通儿科医生对 CDI 的认识有限以及对高技能专科护理和适当劳动力能力的需求相关的医疗保健系统挑战。还需要提高认识并对医疗保健专业人员和患者进行 CDI 各个方面的教育,以支持改善护理和患者与医疗保健专业人员的有效互动。我们反思了这些信息并强调了改进的机会。这些涉及制定指南以支持患者、照顾者、初级保健医生和普通儿科医生更早地识别临床特征,并在患者出现提示症状时考虑将 CDI 作为可能的诊断。